Daniel Loeb acquired 1.22 Million Neurocrine Biosciences shares worth $167 Million. That's 2.38% of their equity portfolio (16th largest holding). The investor owns 1.22% of the outstanding Neurocrine Biosciences stock. Daniel Loeb acquired their 1.22 Million shares between 2006 and 2007. So far they never sold any shares in the company. The stake costed the investor $12.9 Million, netting the investor a gain of 1198% so far.